Your browser doesn't support javascript.
loading
CTRP6 promotes the macrophage inflammatory response, and its deficiency attenuates LPS-induced inflammation.
Xu, Cheng; Sarver, Dylan C; Lei, Xia; Sahagun, Ageline; Zhong, Jun; Na, Chan Hyun; Rudich, Assaf; Wong, G William.
Affiliation
  • Xu C; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sarver DC; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lei X; Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, Oklahoma, USA.
  • Sahagun A; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Zhong J; Delta Omics Inc, Baltimore, Maryland, USA.
  • Na CH; Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Rudich A; Faculty of Health Sciences, Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Wong GW; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: gwwong@jhmi.edu.
J Biol Chem ; 300(1): 105566, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38103643
ABSTRACT
Macrophages play critical roles in inflammation and tissue homeostasis, and their functions are regulated by various autocrine, paracrine, and endocrine factors. We have previously shown that CTRP6, a secreted protein of the C1q family, targets both adipocytes and macrophages to promote obesity-linked inflammation. However, the gene programs and signaling pathways directly regulated by CTRP6 in macrophages remain unknown. Here, we combine transcriptomic and phosphoproteomic analyses to show that CTRP6 activates inflammatory gene programs and signaling pathways in mouse bone marrow-derived macrophages (BMDMs). Treatment of BMDMs with CTRP6 upregulated proinflammatory, and suppressed the antiinflammatory, gene expression. We also showed that CTRP6 activates p44/42-MAPK, p38-MAPK, and NF-κB signaling pathways to promote inflammatory cytokine secretion from BMDMs, and that pharmacologic inhibition of these signaling pathways markedly attenuated the effects of CTRP6. Pretreatment of BMDMs with CTRP6 also sensitized and potentiated the BMDMs response to lipopolysaccharide (LPS)-induced inflammatory signaling and cytokine secretion. Consistent with the metabolic phenotype of proinflammatory macrophages, CTRP6 treatment induced a shift toward aerobic glycolysis and lactate production, reduced oxidative metabolism, and elevated mitochondrial reactive oxygen species production in BMDMs. Importantly, in accordance with our in vitro findings, BMDMs from CTRP6-deficient mice were less inflammatory at baseline and showed a marked suppression of LPS-induced inflammatory gene expression and cytokine secretion. Finally, loss of CTRP6 in mice also dampened LPS-induced inflammation and hypothermia. Collectively, our findings suggest that CTRP6 regulates and primes the macrophage response to inflammatory stimuli and thus may have a role in modulating tissue inflammatory tone in different physiological and disease contexts.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Lipopolysaccharides / Gene Expression Profiling / Proteomics / Adipokines / Inflammation / Macrophages Limits: Animals Language: En Journal: J Biol Chem Year: 2024 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Lipopolysaccharides / Gene Expression Profiling / Proteomics / Adipokines / Inflammation / Macrophages Limits: Animals Language: En Journal: J Biol Chem Year: 2024 Document type: Article Affiliation country: Estados Unidos
...